GH研究制药 GHRS
$18.61 +$0.17 (+0.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.61 0.00%
开盘$18.56
昨收$18.44
当日区间$18.13 – $18.78
成交量453.6K
市值$1.28B
市盈率（TTM）–
股息率–
GHRS 相关新闻
匹配 GH Research 或代码 GHRS 的头条新闻，按最新排序。
- CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
- Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39 正面
- Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40 正面
- Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40 正面
- TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
- Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
- Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65 负面
- RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
- Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35 正面
- A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39
- Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT) 正面
- H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70
暂无评论——快来第一个聊聊 GHRS。
登录后参与讨论。